Skip to content
10-Q

Quarterly Report

BLACK DIAMOND THERAPEUTICS, INC. BDTX

0001701541-25-000022

← back to feed
Filed
May 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 6, 2025 56.86M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $16.85M
Current Liabilities Q1 2025 · Dec 31, 2024 $20.57M
Total Liabilities Q1 2025 · Mar 31, 2025 $34.73M
Total Liabilities Q1 2025 · Dec 31, 2024 $39.36M
Current Assets Q1 2025 · Mar 31, 2025 $155.68M
Current Assets Q1 2025 · Dec 31, 2024 $101.18M
Total Assets Q1 2025 · Mar 31, 2025 $176.25M
Total Assets Q1 2025 · Dec 31, 2024 $122.64M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $36.44M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $25.42M
Shares Diluted Q1 2025 · Mar 31, 2024 51.81M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$21.2M
Stockholders Equity Q1 2025 · Mar 31, 2024 $104.31M
Stockholders Equity Q1 2025 · Dec 31, 2023 $116.74M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.35
Eps Basic Q1 2025 · Mar 31, 2024 −$0.35
Sga Expense Q1 2025 · Mar 31, 2024 $6.7M
Rd Expense Q1 2025 · Mar 31, 2024 $13.55M
Net Income Q1 2025 · Mar 31, 2024 −$18.23M
Operating Income Q1 2025 · Mar 31, 2024 −$20.25M